Developer docs
API playgroundTry for free, no card

Search company profiles

IR Centers

Full company profile

uuid0006u31

Namestring
IR Centers
Legal namestring
IR Centers USA, LLC
Websiteurl
ircenters.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

IR Centers is a privately held interventional radiology (IR) platform founded in 2020 by Dr. Sandeep Bagla (CEO, President, and Founder) and headquartered in McLean, Virginia, operating as IR Centers USA, LLC. The company delivers minimally invasive, image-guided procedures through affiliated sub-brands—Prostate Centers USA, Hemorrhoid Centers, and Ortho Centers—spanning 25+ markets and 40+ locations across the United States. Its core procedures include Prostatic Artery Embolization (PAE) for benign prostatic hyperplasia (BPH), hemorrhoid embolization, Uterine Fibroid Embolization (UFE), Genicular Artery Embolization (GAE) for knee osteoarthritis, varicocele and pelvic congestion embolization, erectile dysfunction treatments, interventional oncology (including Y-90 radioembolization for liver cancer), and peripheral arterial disease interventions.

Rather than operating standalone facilities, IR Centers embeds its interventional radiologists into established urology, orthopedic, and (planned) gastroenterology practices, embedding equipment, procedural protocols, and clinical-research expertise into host sites while leveraging partner patient flow and specialty referrals. Revenue is generated through professional-services billing for outpatient IR procedures, paid via insurance on a per-procedure basis; pricing is not publicly disclosed. The company is led by Founder/CEO Sandeep Bagla, co-founder Tiffany Ramos, and a clinical leadership team including Chief Medical Officer for Innovation & Development Alex Pavidapha (one of the busiest embolization practitioners in the U.S.) and Medical Director Ari Isaacson, supported by research leadership underwritten by the founder's role as principal investigator on multiple clinical trials and authorship of peer-reviewed studies and multisociety consensus documents. Distribution is partnership-led with embedded field-based relationship development, complemented by a multi-channel marketing mix including a website, educational videos, publications, webinars, and medical-conference partnerships (e.g., STREAM Meeting). Ownership appears founder-controlled with no disclosed institutional or PE backing.

Short descriptiontext

IR Centers is a privately held interventional radiology platform that partners with urology, orthopedic, and gastroenterology practices to deliver minimally invasive, image-guided embolization and IR procedures across 40+ outpatient locations in 25+ U.S. markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMclean, United States
HQ citystring
Mclean
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices40 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
interventional radiology services, minimally invasive procedures, prostate artery embolization, outpatient embolization treatments, image-guided therapies
Industry2 codes
1Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)
CodeHLAFAKABPrimaryYes
2Nuclear Medicine Clinical Services & Therapy Centers
CodeHLAIAGAIPrimaryNo
NAICS code2 codes
  • Offices of Physicians62111
  • Ambulatory Health Care Services621
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Interventional Radiology Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Outpatient IR Procedure Services
TypeProfessional Services
Description

Revenue generated from providing minimally invasive, image-guided interventional radiology procedures in outpatient settings through partner practice affiliations. Services include embolization therapies, advanced imaging protocols, and various outpatient IR treatments.

ircenters.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

IR Centers provides minimally invasive, image-guided interventional radiology (IR) procedures — primarily embolization therapies — delivered through partnerships with established urology, orthopedic, and gastroenterology practices. Core treatments include Prostate Artery Embolization (PAE) for BPH, hemorrhoid embolization, uterine fibroid embolization (UFE), and genicular artery embolization (GAE) for knee osteoarthritis, along with related vascular and interventional oncology services. The company operates across 25+ U.S. markets with 40+ locations, embedding IR specialists into outpatient care settings rather than operating standalone facilities.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

IR Centers is an interventional radiology platform offering a portfolio of minimally invasive, image-guided treatments through affiliated sub-brands including Prostate Centers USA, Hemorrhoid Centers, and Ortho Centers. The platform operates across 25+ markets with over 40 locations, partnering with urology, orthopedic, and other specialty practices to deliver outpatient IR procedures. The core treatments include Prostatic Artery Embolization (PAE) for BPH, hemorrhoid embolization, uterine fibroid embolization (UFE), genicular artery embolization (GAE) for knee arthritis, and broader vascular/interventional oncology procedures. The company provides these services through affiliated partner practice locations rather than operating standalone facilities.

Product and service11 records
1Prostatic Artery Embolization (PAE)
CategoryMen's Urologic Health
2Hemorrhoid Embolization
CategoryHemorrhoid Treatment
3Uterine Fibroid Embolization (UFE)
CategoryWomen's Health
4Genicular Artery Embolization (GAE)
CategoryMusculoskeletal Treatment
5Pelvic Congestion Syndrome Treatment
CategoryWomen's Health
6Varicocele Embolization
CategoryMen's Health
7Erectile Dysfunction & Men's Health Treatments
CategoryMen's Health
8Liver Cancer Treatments
CategoryInterventional Oncology
9Peripheral Arterial Disease (PAD) Treatment
CategoryVascular Disease Treatment
10Hip Arthritis Treatment
CategoryMusculoskeletal Treatment
11Frozen Shoulder Treatment
CategoryMusculoskeletal Treatment
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-10
Description

Launched advanced outpatient interventional radiology program in Richmond to expand access to minimally invasive therapies in Central Virginia. Collaboration integrates embolization therapies and advanced imaging protocols into Virginia Urology's care continuum.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-02
Description

Launched new outpatient interventional radiology program in Alabama, expanding access to minimally invasive embolization therapies and advanced imaging. Represents significant expansion of IR Centers' national model.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-01
Description

Grand opening of advanced interventional radiology program in El Paso, Texas in partnership with Rio Grande Urology. Offers minimally invasive therapies including embolization procedures to expand access to specialized care in West Texas.

4New Jersey Urology
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Practice partnership to open IR radiology sites offering minimally invasive, image-guided procedures including advanced embolization therapies for benign prostatic hyperplasia and hemorrhoidal disease. Several New Jersey sites slated for 2026.

radiologybusiness.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership in Southern California to provide IR services at urology practice locations, offering advanced embolization therapies and image-guided procedures.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership to host interventional radiology event at Archer Hotel Tysons Corner, Virginia featuring live cases and discussions on malpractice, contracts, and career development for IR residents. Aims to prepare future IR leaders with procedural and business skills.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Donated imaging equipment to support IR training in East Africa with deployment across the region. Initiative includes establishing remote streaming education systems to improve access to minimally invasive treatments and enhance local training capacity.

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Aledade partners with independent primary care and specialty physician practices to help them succeed in value-based care arrangements, offering technology, analytics, and network support. Direct peer on partnership-led distribution into existing physician practices, although Aledade's focus is PCP-led ACO enablement rather than procedural services.

TypeDirect peer
Description

Solis Mammography is a specialty outpatient platform operating dedicated breast imaging centers under a unified national brand, often co-located within or partnered with OB/GYN and primary care practices. Closely comparable model to IR Centers: specialty outpatient services embedded in partner practices, scaled nationally under a focused condition-specific brand (analogous to Prostate Centers USA / Hemorrhoid Centers).

TypeEmerging player
Description

U.S. Physical Therapy operates a national network of outpatient physical and occupational therapy clinics, many built through joint venture partnerships with local therapists. Comparable specialty outpatient roll-up with partnership-driven site expansion, though in the rehabilitation/musculoskeletal lane rather than image-guided procedural care.

TypeBroad incumbent
Description

Boston Scientific markets the Rezum system, a transurethral water vapor thermal therapy for BPH used by urologists. Competes head-to-head with IR Centers' PAE procedure for the same BPH patient population, leveraging Boston Scientific's scale, established urology sales force, and device-based distribution model.

TypeEmerging player
Description

Agilon Health partners with primary care physician groups to take global risk for senior populations, scaling its partnership model across geographies. Comparable in its reliance on multi-state physician practice partnerships for national scale, though Agilon operates in a value-based care and senior care lane rather than procedural specialty services.

TypeDirect peer
Description

Procept BioRobotics markets Aquablation and previously UroLift, devices used by urologists to treat BPH as alternatives to surgery. Direct competitor in the same patient indication (BPH/enlarged prostate) that IR Centers' Prostate Centers USA addresses, competing for the same urologist referrals and patients seeking non-surgical BPH solutions.

TypeDirect peer
Description

Privia Health is a physician-enablement platform that partners with independent medical groups across multiple specialties, providing technology, practice operations, and value-based care infrastructure. Highly comparable GTM motion: enters markets by forming long-term strategic partnerships with existing practices rather than building de novo clinics, mirroring IR Centers' embedded partnership approach with urology groups.

TypeBroad incumbent
Description

Optum's Surgical Care Affiliates is one of the largest ambulatory surgery center (ASC) platforms in the U.S., operating multi-specialty outpatient surgical facilities. Comparable as a scaled outpatient procedural services platform, though Optum/SCA owns and operates its facilities whereas IR Centers embeds in partner practice sites.

TypeBroad incumbent
Description

RadNet is the largest outpatient diagnostic imaging network in the U.S., operating freestanding imaging centers across multiple modalities. Comparable as a multi-site outpatient radiology services platform, but focused primarily on diagnostic imaging rather than therapeutic interventional radiology procedures like IR Centers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IR Centers

Interventional Radiology Servicesircenters.com

IR Centers is a privately held interventional radiology platform that partners with urology, orthopedic, and gastroenterology practices to deliver minimally invasive, image-guided embolization and IR procedures across 40+ outpatient locations in 25+ U.S. markets.

What IR Centers does

IR Centers is a privately held interventional radiology (IR) platform founded in 2020 by Dr. Sandeep Bagla (CEO, President, and Founder) and headquartered in McLean, Virginia, operating as IR Centers USA, LLC. The company delivers minimally invasive, image-guided procedures through affiliated sub-brands—Prostate Centers USA, Hemorrhoid Centers, and Ortho Centers—spanning 25+ markets and 40+ locations across the United States. Its core procedures include Prostatic Artery Embolization (PAE) for benign prostatic hyperplasia (BPH), hemorrhoid embolization, Uterine Fibroid Embolization (UFE), Genicular Artery Embolization (GAE) for knee osteoarthritis, varicocele and pelvic congestion embolization, erectile dysfunction treatments, interventional oncology (including Y-90 radioembolization for liver cancer), and peripheral arterial disease interventions.

Rather than operating standalone facilities, IR Centers embeds its interventional radiologists into established urology, orthopedic, and (planned) gastroenterology practices, embedding equipment, procedural protocols, and clinical-research expertise into host sites while leveraging partner patient flow and specialty referrals. Revenue is generated through professional-services billing for outpatient IR procedures, paid via insurance on a per-procedure basis; pricing is not publicly disclosed. The company is led by Founder/CEO Sandeep Bagla, co-founder Tiffany Ramos, and a clinical leadership team including Chief Medical Officer for Innovation & Development Alex Pavidapha (one of the busiest embolization practitioners in the U.S.) and Medical Director Ari Isaacson, supported by research leadership underwritten by the founder's role as principal investigator on multiple clinical trials and authorship of peer-reviewed studies and multisociety consensus documents. Distribution is partnership-led with embedded field-based relationship development, complemented by a multi-channel marketing mix including a website, educational videos, publications, webinars, and medical-conference partnerships (e.g., STREAM Meeting). Ownership appears founder-controlled with no disclosed institutional or PE backing.

IR Centers firmographics

Firmographics
Name
IR Centers
Legal name
IR Centers USA, LLC
Website
https://ircenters.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
51–100 employees
Short description
IR Centers is a privately held interventional radiology platform that partners with urology, orthopedic, and gastroenterology practices to deliver minimally invasive, image-guided embolization and IR procedures across 40+ outpatient locations in 25+ U.S. markets.
Ownership category
akta.pro rank

IR Centers industry classification

Industry
Product category
Interventional Radiology Services
NAICS
Offices of Physicians (62111), Ambulatory Health Care Services (621)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)
akta.pro secondary industry
Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)

Keywords

  • Interventional radiology services
  • Minimally invasive procedures
  • Prostate artery embolization
  • Outpatient embolization treatments
  • Image-guided therapies

Where IR Centers is headquartered

Location

Headquarters

HQ city
Mclean
HQ country
United States
HQ region
North America

Offices40 records

Markets served

IR Centers business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Outpatient IR Procedure Services: Revenue generated from providing minimally invasive, image-guided interventional radiology procedures in outpatient settings through partner practice affiliations. Services include embolization therapies, advanced imaging protocols, and various outpatient IR treatments.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

IR Centers product offering

Product offering

Core offering

IR Centers provides minimally invasive, image-guided interventional radiology (IR) procedures — primarily embolization therapies — delivered through partnerships with established urology, orthopedic, and gastroenterology practices. Core treatments include Prostate Artery Embolization (PAE) for BPH, hemorrhoid embolization, uterine fibroid embolization (UFE), and genicular artery embolization (GAE) for knee osteoarthritis, along with related vascular and interventional oncology services. The company operates across 25+ U.S. markets with 40+ locations, embedding IR specialists into outpatient care settings rather than operating standalone facilities.

Product overview

IR Centers is an interventional radiology platform offering a portfolio of minimally invasive, image-guided treatments through affiliated sub-brands including Prostate Centers USA, Hemorrhoid Centers, and Ortho Centers. The platform operates across 25+ markets with over 40 locations, partnering with urology, orthopedic, and other specialty practices to deliver outpatient IR procedures. The core treatments include Prostatic Artery Embolization (PAE) for BPH, hemorrhoid embolization, uterine fibroid embolization (UFE), genicular artery embolization (GAE) for knee arthritis, and broader vascular/interventional oncology procedures. The company provides these services through affiliated partner practice locations rather than operating standalone facilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • Prostatic Artery Embolization (PAE)
  • Hemorrhoid Embolization
  • Uterine Fibroid Embolization (UFE)
  • Genicular Artery Embolization (GAE)
  • Pelvic Congestion Syndrome Treatment
  • Varicocele Embolization
  • Erectile Dysfunction & Men's Health Treatments
  • Liver Cancer Treatments
  • Peripheral Arterial Disease (PAD) Treatment
  • Hip Arthritis Treatment
  • Frozen Shoulder Treatment

Companies that use IR Centers

Customer profile

Named customers3 records

Segments6 records

Ideal customer profiles2 records

IR Centers technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

IR Centers partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Virginia UrologycoreStrategic or Co-development Partner · 10 December 2025Launched advanced outpatient interventional radiology program in Richmond to expand access to minimally invasive therapies in Central Virginia. Collaboration integrates embolization therapies and advanced imaging protocols into Virginia Urology's care continuum.
  • Urology Associates of MobilecoreStrategic or Co-development Partner · 2 December 2025Launched new outpatient interventional radiology program in Alabama, expanding access to minimally invasive embolization therapies and advanced imaging. Represents significant expansion of IR Centers' national model.
  • Rio Grande UrologycoreStrategic or Co-development Partner · 1 December 2025Grand opening of advanced interventional radiology program in El Paso, Texas in partnership with Rio Grande Urology. Offers minimally invasive therapies including embolization procedures to expand access to specialized care in West Texas.
  • New Jersey UrologycoreStrategic or Co-development PartnerPractice partnership to open IR radiology sites offering minimally invasive, image-guided procedures including advanced embolization therapies for benign prostatic hyperplasia and hemorrhoidal disease. Several New Jersey sites slated for 2026.
  • Orange County Urology AssociatescoreStrategic or Co-development PartnerPartnership in Southern California to provide IR services at urology practice locations, offering advanced embolization therapies and image-guided procedures.
  • STREAM MeetingminorStrategic or Co-development PartnerPartnership to host interventional radiology event at Archer Hotel Tysons Corner, Virginia featuring live cases and discussions on malpractice, contracts, and career development for IR residents. Aims to prepare future IR leaders with procedural and business skills.
  • Road2IRminorStrategic or Co-development PartnerDonated imaging equipment to support IR training in East Africa with deployment across the region. Initiative includes establishing remote streaming education systems to improve access to minimally invasive treatments and enhance local training capacity.

Scale indicators2 records

Recent moves11 records

Expansion highlights4 records

IR Centers competitors and assessment

Company assessment

Direct peers

  • Aledade: Aledade partners with independent primary care and specialty physician practices to help them succeed in value-based care arrangements, offering technology, analytics, and network support. Direct peer on partnership-led distribution into existing physician practices, although Aledade's focus is PCP-led ACO enablement rather than procedural services.
  • Solis Mammography: Solis Mammography is a specialty outpatient platform operating dedicated breast imaging centers under a unified national brand, often co-located within or partnered with OB/GYN and primary care practices. Closely comparable model to IR Centers: specialty outpatient services embedded in partner practices, scaled nationally under a focused condition-specific brand (analogous to Prostate Centers USA / Hemorrhoid Centers).
  • Procept BioRobotics: Procept BioRobotics markets Aquablation and previously UroLift, devices used by urologists to treat BPH as alternatives to surgery. Direct competitor in the same patient indication (BPH/enlarged prostate) that IR Centers' Prostate Centers USA addresses, competing for the same urologist referrals and patients seeking non-surgical BPH solutions.
  • Privia Health: Privia Health is a physician-enablement platform that partners with independent medical groups across multiple specialties, providing technology, practice operations, and value-based care infrastructure. Highly comparable GTM motion: enters markets by forming long-term strategic partnerships with existing practices rather than building de novo clinics, mirroring IR Centers' embedded partnership approach with urology groups.

Emerging players

  • U.S. Physical Therapy: U.S. Physical Therapy operates a national network of outpatient physical and occupational therapy clinics, many built through joint venture partnerships with local therapists. Comparable specialty outpatient roll-up with partnership-driven site expansion, though in the rehabilitation/musculoskeletal lane rather than image-guided procedural care.
  • Agilon Health: Agilon Health partners with primary care physician groups to take global risk for senior populations, scaling its partnership model across geographies. Comparable in its reliance on multi-state physician practice partnerships for national scale, though Agilon operates in a value-based care and senior care lane rather than procedural specialty services.

Broad incumbents

  • Concentra (Select Medical Holdings):
  • Boston Scientific (Rezum): Boston Scientific markets the Rezum system, a transurethral water vapor thermal therapy for BPH used by urologists. Competes head-to-head with IR Centers' PAE procedure for the same BPH patient population, leveraging Boston Scientific's scale, established urology sales force, and device-based distribution model.
  • Optum (Surgical Care Affiliates): Optum's Surgical Care Affiliates is one of the largest ambulatory surgery center (ASC) platforms in the U.S., operating multi-specialty outpatient surgical facilities. Comparable as a scaled outpatient procedural services platform, though Optum/SCA owns and operates its facilities whereas IR Centers embeds in partner practice sites.
  • RadNet: RadNet is the largest outpatient diagnostic imaging network in the U.S., operating freestanding imaging centers across multiple modalities. Comparable as a multi-site outpatient radiology services platform, but focused primarily on diagnostic imaging rather than therapeutic interventional radiology procedures like IR Centers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

IR Centers social profiles

Digital presence

IR Centers compliance and trust

Trust signal

Compliance2 records

IR Centers financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IR Centers leadership team

Management profile

Number of profiles

Profiles3 records

IR Centers funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IR Centers M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IR Centers

What does IR Centers do?

IR Centers provides minimally invasive, image-guided interventional radiology (IR) procedures — primarily embolization therapies — delivered through partnerships with established urology, orthopedic, and gastroenterology practices. Core treatments include Prostate Artery Embolization (PAE) for BPH, hemorrhoid embolization, uterine fibroid embolization (UFE), and genicular artery embolization (GAE) for knee osteoarthritis, along with related vascular and interventional oncology services. The company operates across 25+ U.S. markets with 40+ locations, embedding IR specialists into outpatient care settings rather than operating standalone facilities.

Is IR Centers a public or private company?

IR Centers is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was IR Centers founded?

IR Centers was founded in 2020. It employs 51 to 100 people.

Where is IR Centers based?

IR Centers is headquartered in Mclean, United States, in the North America region.

How does IR Centers make money?

One revenue line is on record: outpatient IR Procedure Services.

Who are IR Centers's main competitors?

Direct peers on record are Aledade, Solis Mammography, Procept BioRobotics and Privia Health. Emerging players are U.S. Physical Therapy and Agilon Health. Broad incumbents are Concentra (Select Medical Holdings), Boston Scientific (Rezum), Optum (Surgical Care Affiliates) and RadNet.

Does IR Centers have an API?

No public API is recorded for IR Centers.

What industry is IR Centers in?

IR Centers's product category is Interventional Radiology Services. Its primary akta.pro industry code is HLAFAKAB, Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology), with a secondary code of HLAIAGAI, Nuclear Medicine Clinical Services & Therapy Centers. Its NAICS code is 62111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireIR Centers® and Michigan Institute of Urology Announce Expansion of Clinical Operations in MichiganIR Centers and Michigan Institute of Urology expanded their collaboration to a third outpatient interventional radiology lab in Southeast Michigan, adding board-certified radiologist Jeremy Handel, MD. The expansion increases procedural capacity and reduces wait times for image-guided therapies for conditions like BPH and pelvic venous disorders.EIN PresswireDr. Robert Esposito of IR Centers® at Georgia Urology Named a 2026 Atlanta Magazine Top DoctorDr. Robert Esposito, interventional radiologist at IR Centers at Georgia Urology, was named a 2026 Top Doctor in Vascular and Interventional Radiology by Atlanta magazine. The recognition honors his clinical excellence and minimally invasive care, and the center is part of IR Centers' national platform.EIN PresswireIR Centers® Launches High School Educational Observership Program to Open the Door to MedicineIR Centers launched a High School Educational Observership Program to introduce students to medicine and interventional radiology. The program combines onsite observation at its Falls Church flagship with virtual learning, aiming to inspire future clinicians. It reflects the company's commitment to workforce development and education.Radiology BusinessInterventional radiology group inks 2 more practice partnerships with urologistsIR Centers, an interventional radiology platform founded by Dr. Sandeep Bagla, has announced two new practice partnerships with urology groups: New Jersey Urology and Orange County Urology Associates in Southern California. The partnerships will open radiology sites offering minimally invasive, image-guided procedures such as advanced embolization therapies, treating conditions including benign prostatic hyperplasia and hemorrhoidal disease. The company has expanded to 25 markets under affiliated brands including Prostate Centers USA, Hemorrhoid Centers, and Ortho Centers, with several New Jersey sites slated for 2026.EIN PresswireIR Centers® and New Jersey Urology Partner to Launch Multiple Advanced IR Centers in 2026IR Centers and New Jersey Urology announced a partnership to launch multiple advanced outpatient interventional radiology centers across New Jersey in 2026. The centers will offer embolization therapies for conditions like BPH and chronic pelvic pain, aiming to expand access to minimally invasive care. The collaboration combines IR Centers' platform with New Jersey Urology's regional footprint.EIN PresswireIR Centers® and Orange County Urology Associates Partner to Launch Advanced IR ProgramIR Centers and Orange County Urology Associates announced a partnership to launch an advanced outpatient interventional radiology program in Orange County. The program will offer embolization therapies for conditions like BPH and chronic pelvic pain, with a center opening planned for 2026.Radiology BusinessInterventional radiology group inks 3 more urology practice partnerships across 3 statesIR Centers, a Falls Church, Virginia-based interventional radiology platform company, has announced three new partnerships with urology practices in Alabama, Texas, and Virginia to expand access to prostate artery embolization procedures. The partnerships follow the American Urological Association's 2023 update to clinical guidelines endorsing the minimally invasive treatment for enlarged prostates. The company estimates it now operates in over 25 markets through such partnerships across 40-plus locations, though some interventional radiologists have raised concerns that the model undermines physician independence by shifting clinical control to non-radiology practices.EIN PresswireIR Centers® and Virginia Urology Launch Advanced Outpatient Interventional Radiology Program in RichmondIR Centers® and Virginia Urology announced the launch of an advanced outpatient interventional radiology program in Richmond, Virginia, expanding access to minimally invasive embolization therapies across Central Virginia. The partnership integrates IR Centers' cutting-edge embolization procedures—including treatments for benign prostatic hyperplasia, chronic pelvic pain, and hemorrhoidal disease—directly into Virginia Urology's established 75-year-old practice spanning seven locations. IR Centers operates in over 25 U.S. markets and brings its national quality program, the largest embolization outcomes registry in the United States, to strengthen clinical standardization and patient outcomes in the Mid-Atlantic region.EIN PresswireIR Centers and Urology Associates of Mobile Launch Advanced Interventional Radiology Program in AlabamaIR Centers and Urology Associates of Mobile announced the launch of an advanced outpatient interventional radiology program in Mobile, Alabama, marking a significant expansion of IR Centers' national footprint across the Gulf Coast region. The partnership brings minimally invasive therapies including Prostatic Artery Embolization (PAE), hemorrhoid artery embolization, and targeted oncologic interventions directly to patients in Mobile, Baldwin County, and surrounding areas, eliminating the need for long-distance travel to access these procedures. The program reflects IR Centers' continued growth strategy through partnerships with Urology Management Associates-affiliated practices, operating under the company's national quality standards and outcomes registry.EIN PresswireIR Centers and Rio Grande Urology Announce Grand Opening of Advanced Interventional Radiology Program in El PasoIR Centers® and Rio Grande Urology announced the grand opening of a new outpatient interventional radiology program in El Paso, Texas, bringing advanced embolization therapies and minimally invasive procedures to West Texas patients. The partnership combines IR Centers' nationally recognized clinical standards and quality registry with Rio Grande Urology's established regional urology practice, marking IR Centers' third Texas location alongside Austin and Dallas. The collaboration is positioned as one of the most comprehensive IR-urology integrations in the United States, offering procedures such as Prostatic Artery Embolization, hemorrhoid artery embolization, and genicular artery embolization in a fully integrated outpatient model.